Leishmanial sphingolipid induces apoptosis in Sarcoma 180 cancer cells through regulation of tumour growth via angiogenic switchover
- 19 December 2014
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 36 (4) , 3109-3118
Abstract
Sphingolipids are membrane and intracellular lipids that typically modulate cellular processes to cause cell death. Exogenous administration of sphingolipids may cause restriction of tumour growth and several alternative strategies are being used to control the cell growth. The microbes, their cellular component(s) or metabolites like DHA, EPA and also FTY720 have been employed as new therapeutic entities to regulate the disease condition. The therapeutic efficacy of lipids from Leishmania donovani in rheumatoid arthritis and also in sepsis condition associated with inflammatory diseases is well established. In this study, we explored the apoptotic effect of LSPL-1 (leishmanial sphingolipid-1) in Sarcoma 180 cells towards the regulation of tumour growth. The study using a panel of cancer cell lines revealed that LSPL-1 induces cell death in Sarcoma 180. The apoptotic changes were assessed by annexin exposure and DNA content analysis using flow cytometry. LSPL-1 appears to activate several pro- and anti-apoptotic molecules through reactive oxygen species (ROS) generation and also caspase activation, as determined by Western blot and ELISA analyses. Simultaneously, it may improve the survival rate of mice bearing tumour induced by Sarcoma 180 cells, with pathological changes. LSPL-1 may also suppress the cancer-associated inflammatory responses with the expression of matrix metalloproteinase having inhibitory role. It may regulate several angiogenic factors including VEGF, Ang-2 and CD34 in angiogenic events generated in Sarcoma 180 cell-induced tumour. These studies underline the significance of anti-neoplastic potential of LSPL-1 through apoptosis induction and abrogation of angiogenic responses in Sarcoma 180 cell-associated tumour.Keywords
This publication has 33 references indexed in Scilit:
- Anticancer Potential of 3-(Arylideneamino)-2-Phenylquinazoline-4(3H)-One DerivativesCellular Physiology and Biochemistry, 2012
- Anti-tumor effect of Liqi, a traditional Chinese medicine prescription, in tumor bearing miceBMC Complementary and Alternative Medicine, 2009
- Resistance to chemotherapy: new treatments and novel insights into an old problemBritish Journal of Cancer, 2008
- Leishmanial lipid suppresses tumor necrosis factor α, interleukin‐1β, and nitric oxide production by adherent synovial fluid mononuclear cells in rheumatoid arthritis patients and induces apoptosis through the mitochondrial‐mediated pathwayArthritis & Rheumatism, 2008
- FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphomaBlood, 2008
- The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytesCarcinogenesis, 2005
- Microorganisms and Cancer: Quest for a TherapyJournal of Bacteriology, 2003
- Sphingolipids and the regulation of the immune responseSeminars in Immunology, 2002
- A modified benzidine method for the chromatographic detection of sphingolipids and acid polysaccharidesBiochimica et Biophysica Acta, 1963
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959